These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 27015862)
1. The roles of Nakano Y; Noguchi M; Yokoi-Noguchi M; Ohno Y; Morioka E; Kosaka T; Takahashi T; Minato H Breast Cancer; 2017 Jan; 24(1):121-127. PubMed ID: 27015862 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer. Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913 [TBL] [Abstract][Full Text] [Related]
3. The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes. Usmani S; Ahmed N; Al Saleh N; abu Huda F; Amanguno HG; Amir T; al Kandari F Eur J Radiol; 2015 Dec; 84(12):2515-20. PubMed ID: 26474908 [TBL] [Abstract][Full Text] [Related]
4. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer. Fujii T; Yajima R; Tatsuki H; Kuwano H Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160 [TBL] [Abstract][Full Text] [Related]
5. Initial axillary staging of breast cancer using ultrasound-guided fine needle aspiration: a liquid-based cytology study. Schiettecatte A; Bourgain C; Breucq C; Buls N; De Wilde V; de Mey J Cytopathology; 2011 Feb; 22(1):30-5. PubMed ID: 20337693 [TBL] [Abstract][Full Text] [Related]
6. The role of preoperative axillary ultrasound and fine-needle aspiration cytology in identifying patients with extensive axillary lymph node involvement. Maráz R; Zombori T; Ambrózay É; Cserni G Eur J Surg Oncol; 2017 Nov; 43(11):2021-2028. PubMed ID: 28919032 [TBL] [Abstract][Full Text] [Related]
7. FDG-PET for axillary lymph node staging in primary breast cancer. Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635 [TBL] [Abstract][Full Text] [Related]
9. Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography, sonography, and sonographically guided fine-needle aspiration biopsy in the diagnosis of axillary lymph nodes in patients with breast cancer: comparison of diagnostic performance. Sohn YM; Hong IK; Han K J Ultrasound Med; 2014 Jun; 33(6):1013-21. PubMed ID: 24866608 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229 [TBL] [Abstract][Full Text] [Related]
11. Axillary staging by ultrasound-guided fine-needle aspiration cytology in breast cancer patients. Still up to date? Leenders M; Richir M; Broeders M; Moormann G; Mollema R; Lopes Cardozo A; Meijer S; Schreurs H Breast J; 2013; 19(6):637-42. PubMed ID: 24011125 [TBL] [Abstract][Full Text] [Related]
12. Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer. Gil-Rendo A; Zornoza G; García-Velloso MJ; Regueira FM; Beorlegui C; Cervera M Br J Surg; 2006 Jun; 93(6):707-12. PubMed ID: 16622900 [TBL] [Abstract][Full Text] [Related]
13. Axillary dissection in patients with preoperative positive nodal cytology: Genuine need or overtreatment? Liberale V; Rosso R; Arisio R; D'Alonzo M; Villasco A; Fuso L; De Sanctis C; Modaffari P; Biglia N Breast J; 2020 Feb; 26(2):168-175. PubMed ID: 31448500 [TBL] [Abstract][Full Text] [Related]
14. Preoperative ultrasound-guided fine-needle aspiration cytology for axillary staging in breast carcinoma. Popli MB; Sahoo M; Mehrotra N; Choudhury M; Kumar A; Pathania OP; Thomas S Australas Radiol; 2006 Apr; 50(2):122-6. PubMed ID: 16635029 [TBL] [Abstract][Full Text] [Related]
15. Clinical utility of routine pre-operative axillary ultrasound and fine needle aspiration cytology in patient selection for sentinel lymph node biopsy. Rattay T; Muttalib M; Khalifa E; Duncan A; Parker SJ Breast; 2012 Apr; 21(2):210-4. PubMed ID: 21981897 [TBL] [Abstract][Full Text] [Related]
16. Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study. Pritchard KI; Julian JA; Holloway CM; McCready D; Gulenchyn KY; George R; Hodgson N; Lovrics P; Perera F; Elavathil L; O'Malley FP; Down N; Bodurtha A; Shelley W; Levine MN J Clin Oncol; 2012 Apr; 30(12):1274-9. PubMed ID: 22393089 [TBL] [Abstract][Full Text] [Related]
17. Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011. Boland MR; Prichard RS; Daskalova I; Lowery AJ; Evoy D; Geraghty J; Rothwell J; Quinn CM; O'Doherty A; McDermott EW Eur J Surg Oncol; 2015 Apr; 41(4):559-65. PubMed ID: 25648466 [TBL] [Abstract][Full Text] [Related]
18. Axillary Staging of Early-Stage Invasive Breast Cancer by Ultrasound-Guided Fine-Needle Aspiration Cytology: Which Ultrasound Criteria for Classifying Abnormal Lymph Nodes Should Be Adopted in the Post-ACOSOG Z0011 Trial Era? Zhu Y; Zhou W; Zhou JQ; Fei XC; Ye TJ; Huang O; Chen XS; Zhan WW J Ultrasound Med; 2016 May; 35(5):885-93. PubMed ID: 27009312 [TBL] [Abstract][Full Text] [Related]
19. Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy. Fehr MK; Hornung R; Varga Z; Burger D; Hess T; Haller U; Fink D; von Schulthess GK; Steinert HC Breast J; 2004; 10(2):89-93. PubMed ID: 15009033 [TBL] [Abstract][Full Text] [Related]
20. Discordant results in Parisse-Di Martino S; Faure C; Mognetti T Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]